06/09/2026
The Foundation has received a link to a review on SPG4 and acknowledges the efforts of the researchers involved for such a thorough, detailed, deep-dive examination of the challenges, uncertainties, conundrums and questions that are central to making progress towards clinical trials and developing disease-modifying therapies for SPG4.
"It’s a pleasure to share with you our recently published commentary/review on SPG4 HSP. The focus is on etiology and therapy.
Please feel free to share with others in our community.
Peter W. Baas, PhD
Professor, Department of Neurobiology and Anatomy
Drexel University College of Medicine
2900 Queen Lane
There is no cure for the rare disease Hereditary Spastic Paraplegia (HSP), but researchers from Drexel University’s College of Medicine and the UMass Chan Medical School have achieved proof-of-principle success with “silence and replace” gene therapy — an approach that uses a viral vector to...